Thursday, January 10, 2013
Synageva BioPharma Corp., of Lexington, Mass., closed a public offering of about 2.5 million shares of common stock, including 322,500 shares issued pursuant to an underwriters' option, at $47.53 per share.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.